The South Carolina Legislature is poised to legalize medical cannabis, but the bill that could make that happen might still fail.
The measure in question – S. 150 – has passed the state Senate and was approved easily Thursday by a House committee after a few amendments, the Associated Press reported.
That action set the stage for a full House floor vote.
However, the Associated Press noted, the bill has both bipartisan support and opposition in the House, making the measure’s ultimate fate still unclear.
If the bill were to pass and ultimately become law, it would establish the latest MMJ market in the South – and a very restrictive one.
Under the bill, marijuana flower would remain prohibited, and the list of qualifying medical conditions for registered patients would be relatively thin, including only:
- Cachexia or wasting syndrome
- Chronic muscle spasms
- Crohn’s disease
- Epilepsy or another seizure disorder
- Multiple sclerosis
- Persistent nausea for hospice or homebound patients
- Post-traumatic stress disorder
- Sickle cell anemia
- Ulcerative colitis
Are you a social equity cannabis license holder or applicant?
The MJBizCon team is now accepting 2023 Social Equity Scholarship Program applications.
The mission of this program is to provide social equity cannabis license holders or applicants access to the #1 global cannabis industry conference + tradeshow in Las Vegas.
Who can apply?
- Students currently enrolled in a cannabis-related program at an accredited university or college.
- Cannabis executives at licensed social equity cultivation, extraction/processing, retail, manufacturing/brand businesses (or awaiting application approval).
Don’t miss out on this potentially life-changing opportunity.
Apply to attend MJBizCon today – The application period will close on July 24!
The only medical marijuana products allowed would be oils, salves, patches or vaporizers, the AP reported, and only a select few pharmacies would be permitted to sell them, akin to Louisiana’s MMJ industry structure.
Also, South Carolina patients would be allowed to purchase only up to a two-week supply of medicine at a time.